Shire plc : FDA APPROVES VONVENDI® FOR PERIOPERATIVE MANAGEMENT OF BLEEDING IN ADULT PATIENTS WITH VON WILLEBRAND DISEASE

NEXT STORY
Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting
PREV STORY
Armor Express to Showcase Its Advanced Protective Solutions for Fire and EMS Officers at the 2018 Fire Department Instructor’s Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UCHealth Memorial Hospital Central designated by state as southern Colorado’s first Level I trauma center

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

MindBeacon launches new Digital Alcohol Use Management Therapy Program in consultation with experts from the Centre for Addiction and Mental health

author_avatar
NASDAQ Market News